|
|
Volumn 48, Issue 12, 2012, Pages 811-815
|
|
20th United European Gastroenterology Week 2012 (October 20-24 2012 - Amsterdam, The Netherlands)
|
|
Author keywords
Adalimumab; Budesonide MMX; TD 1211; Teduglutide; Vedolizumab
|
|
Indexed keywords
ADALIMUMAB;
BUDESONIDE;
BUDESONIDE MMX;
MU OPIATE RECEPTOR ANTAGONIST;
OPIATE;
PLACEBO;
TD 1211;
TEDUGLUTIDE;
UNCLASSIFIED DRUG;
VEDOLIZUMAB;
ANTIINFLAMMATORY AGENT;
MONOCLONAL ANTIBODY;
NARCOTIC ANALGESIC AGENT;
CONFERENCE PAPER;
CONSTIPATION;
CROHN DISEASE;
DIGESTIVE SYSTEM DISEASE;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
DRUG TOLERABILITY;
ENTEROPATHY;
ESOPHAGUS DISEASE;
GALLBLADDER DISEASE;
GASTROENTEROLOGY;
GASTROINTESTINAL SYMPTOM;
HUMAN;
LIVER DISEASE;
MAINTENANCE THERAPY;
NETHERLANDS;
OBESITY;
OPEN STUDY;
PANCREAS DISEASE;
PHASE 3 CLINICAL TRIAL (TOPIC);
RISK REDUCTION;
SHORT BOWEL SYNDROME;
STOMACH DISEASE;
TREATMENT DURATION;
TREATMENT RESPONSE;
ULCERATIVE COLITIS;
UNSPECIFIED SIDE EFFECT;
CHEMICALLY INDUCED DISORDER;
ANALGESICS, OPIOID;
ANTI-INFLAMMATORY AGENTS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
BUDESONIDE;
CLINICAL TRIALS, PHASE III AS TOPIC;
CONSTIPATION;
GASTROENTEROLOGY;
HUMANS;
|
|
EID: 84871574005
PISSN: 16993993
EISSN: 16994019
Source Type: Journal
DOI: 10.1358/dot.2012.48.12.1902802 Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|
